Millennium Management LLC Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Millennium Management LLC reduced its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 78.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,893 shares of the company's stock after selling 32,385 shares during the quarter. Millennium Management LLC's holdings in Prestige Consumer Healthcare were worth $694,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of PBH. Caprock Group LLC acquired a new stake in shares of Prestige Consumer Healthcare in the fourth quarter worth approximately $210,000. Choreo LLC boosted its stake in shares of Prestige Consumer Healthcare by 29.9% in the fourth quarter. Choreo LLC now owns 14,100 shares of the company's stock worth $1,091,000 after acquiring an additional 3,249 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Prestige Consumer Healthcare by 3.1% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock worth $126,274,000 after acquiring an additional 49,331 shares during the last quarter. Congress Asset Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 5.0% in the fourth quarter. Congress Asset Management Co. now owns 908,742 shares of the company's stock worth $70,964,000 after acquiring an additional 43,619 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of Prestige Consumer Healthcare by 3.2% in the fourth quarter. Principal Financial Group Inc. now owns 256,526 shares of the company's stock worth $20,032,000 after acquiring an additional 7,890 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Oppenheimer lifted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Wall Street Zen upgraded Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Finally, Royal Bank of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $93.33.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at approximately $1,544,130. This represents a 8.91% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is owned by company insiders.

Prestige Consumer Healthcare Stock Up 0.6%

PBH opened at $85.11 on Friday. The business has a 50 day moving average price of $83.53 and a two-hundred day moving average price of $82.52. The company has a quick ratio of 2.20, a current ratio of 3.68 and a debt-to-equity ratio of 0.56. The company has a market cap of $4.21 billion, a PE ratio of 19.93, a P/E/G ratio of 2.69 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 52 week low of $63.79 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. The firm had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the business earned $1.02 EPS. As a group, research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.